CIPLA
Summary
- Total Recalls
- 11
- 510(k) Clearances
- 0
- Inspections
- 11
- Compliance Actions
- 0
Known Names
cipla, cipla limited
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-1550-2022 | Class II | Arformoterol Tartrate Inhalation Solution, 15 mcg/2mL, 2 mL Sterile Unit-Dose Vial packaged in 5 x 2 | September 29, 2022 |
| D-1545-2022 | Class II | Budesonide Inhalation Suspension 0.25mg/2mL, For Inhalation Only, Rx Only, 1 envelope x five 2 mL Si | September 15, 2022 |
| D-1499-2022 | Class II | Difluprednate Ophthalmic Emulsion, 0.05%, 5 mL bottle, RX only, Manufactured by Cipla Ltd., India, M | August 22, 2022 |
| D-1498-2022 | Class II | Difluprednate Ophthalmic Emulsion, 0.05%, 5 mL bottle, RX only, Manufactured for Exelan Pharmecutica | August 22, 2022 |
| D-1328-2022 | Class II | Difluprednate Ophthalmic Emulsion 0.05%, For Ophthalmic Use Only, Sterile, 5 mL bottles, Manufacture | August 2, 2022 |
| D-1283-2022 | Class II | Difluprednate Ophthalmic Emulsion, 0.05%, 5ml bottles, Rx only, Mfd. by: Cipla Ltd., India At M/S In | July 14, 2022 |
| D-0660-2021 | Class II | Solifenacin Succinate Tablets, 10 mg, 30-count bottles, Rx Only, Manufactured by: Cipla Ltd., Verna, | June 10, 2021 |
| D-0182-2021 | Class II | Esomeprazole Magnesium for Delayed-Release Oral Suspension 20mg, packaged in unit dose packets, Rx o | December 17, 2020 |
| D-0181-2021 | Class II | Esomeprazole Magnesium for Delayed-Release Oral Suspension 10mg, packaged in unit dose packets, Rx o | December 17, 2020 |
| D-0183-2021 | Class II | Esomeprazole Magnesium for Delayed-Release Oral Suspension 40mg, packaged in unit dose packets, Rx o | December 17, 2020 |
| D-0165-2021 | Class II | Azacitidine for Injection 100 mg/vial For Subcutaneous and Intravenous Use Only Single-Dose Vial Man | December 14, 2020 |